Debio 1143: Phase I started

Debiopharm began a Phase I trial to evaluate Debio 1143 plus carboplatin and paclitaxel in patients with non-small cell lung cancer (NSCLC), platinum-refractory ovarian cancer or basal-like/claudin-lo...